Five things for pharma marketers to know: Monday, September 25, 2017

Share this content:

1. The FDA declined to approve Intellipharmaceutics' opioid painkiller after members of a FDA advisory committee expressed concern about the drug's abuse-deterrent properties. The regulator asked the drugmaker to conduct additional studies. (Reuters)

2. The FDA also declined to approve Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab, requesting more information about its safety profile. (Reuters)

3. About 60% of American teenagers have received at least one dose of an HPV vaccine in 2016 — an increase compared to 2015, according to the Centers for Disease Control and Prevention. (NYT)

4. KKR's acquisition of WebMD closed last week. KKR, a private-equity firm that operates Internet Brands, announced plans to acquire WebMD in July. (Drug Store News)

5 .The number of people with diabetes undergoing amputations for their toes, legs, ankles, and feet is growing in California. Diabetes experts are unclear why there has been a rise in amputations. (inewsource)

Share this content:
Scroll down to see the next article